Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-6548 Compared to Darbepoetin Alfa in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
NCT03329196Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Oct 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in anemia, sponsored by Mitsubishi Tanabe Pharma. Started Oct 2017; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03329196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329196.